Literature DB >> 30686389

Therapeutic cannabis use in 2018: where do we stand?

Kevin P Hill1, Matthew D Palastro2, Tony P George3.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 30686389     DOI: 10.1016/S2215-0366(18)30417-6

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  2 in total

1.  A rapid assay provides on-site quantification of tetrahydrocannabinol in oral fluid.

Authors:  Hojeong Yu; Hoyeon Lee; Jiyong Cheong; Sang Won Woo; Juhyun Oh; Hyun-Kyung Oh; Jae-Hyun Lee; Hui Zheng; Cesar M Castro; Yeong-Eun Yoo; Min-Gon Kim; Jinwoo Cheon; Ralph Weissleder; Hakho Lee
Journal:  Sci Transl Med       Date:  2021-10-20       Impact factor: 19.319

2.  The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial.

Authors:  Shlomo Almog; Judith Aharon-Peretz; Simon Vulfsons; Miri Ogintz; Hadas Abalia; Tal Lupo; Yael Hayon; Elon Eisenberg
Journal:  Eur J Pain       Date:  2020-06-12       Impact factor: 3.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.